13F

Stock

Nasus Pharma Ltd

NSRX · held by 9 managers

Reported value

$4.74M

Holders

9

+7 new · −0 exited

Holders’ est. mark

−$16.5K

Price effect on 2 books still in the name

Largest holder

$1.99M

Balyasny Asset Management L.P.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Balyasny Asset Management L.P.898.5K$1.99MNew
Cable Car Capital, LP602K$1.34MNew
Velan Capital Investment Management LP359.4K$797.8KNew
Hudson Bay Capital Management LP134.8K$299.2KNew
Bleichroeder LP89.8K$199.5KNew
Empery Asset Management, LP45.8K$101.7KNew
UBS Group AG3.09K$6.87K−$2.62KAdded$3.41K
MORGAN STANLEY2K$4.44K−$13.9KCut−$13.9K
HRT FINANCIAL LP38.9K$86New

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.